MDCO: Medicines Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MDCO: Medicines Company

MDCO 84.90

0.0%

Jan 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Mike	5/26/2003 10:02:34 AM
	Read Replies (1) of 125

This stock has been consistently rising since last October. The story behind this stock is interesting. But the most important item is we have a shift in care of patients getting angioplasties. Angiomax offers a choice of better,controllable anticoagulation. The sales of Angiomax are rising each and every month. We don't have a doubling of sales but a nice rise. My projection is MDCO will finish 2003 with appox $100MM in sales. This is just based on using Angiomax for angioplasties. Next, we have the clinicals that are being completed for open heart surgery. I think this product and open heart surgery is a match made in heaven. The initial trials of the Angiomax are going to be published in the next month for the 20 pt trial. This is going to bring MDCO to the bigtime if this one hits. Take a look and do some of your own research but this one is for real. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next